Continuous subcutaneous insulin infusion versus multiple daily injection regimens in children and young people at diagnosis of type 1 diabetes: pragmatic randomised controlled trial and economic evaluation.

Affiliation

Department of Endocrinology, Alder Hey Children's NHS Foundation Trust, Liverpool L12 2AP, UK [Email]

Abstract

To compare the efficacy, safety, and cost utility of continuous subcutaneous insulin infusion (CSII) with multiple daily injection (MDI) regimens during the first year following diagnosis of type 1 diabetes in children and young people.

OUR Recent Articles